ReviewJournal of neural transmission (Vienna, Austria : 1996)2026
Lifestyle medicine in Parkinson's disease.
Review in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Non-pharmacological and non-surgical therapies in advanced Parkinson's disease: a narrative review and call to action.Journal of neural transmission (Vienna, Austria : 1996) · 2026Review
- A narrative review of clinical and non-clinical determinants of health-related quality of life in advanced Parkinson's disease.Journal of neural transmission (Vienna, Austria : 1996) · 2026Review
- Neural correlates of Parkinson's improvements after combined digital-levodopa therapy: a pilot study.Brain communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lifestyle medicine is an evolving concept integrating preventive and therapeutic approaches related to physical activity, nutrition, sleep, stress management, social interaction, and cessation of substance abuse aiming to optimize health outcomes. Lifestyle consultation plays an essential and constantly growing role in clinical settings. In this review, we highlight the usability of lifestyle medicine as a framework for both well-established and novel roles of environmental triggers and non-pharmacological prevention and treatment in Parkinson's Disease (PD). We summarize the current understanding of the modulation of PD risk and progression by lifestyle-related domains and provide a review of recent insights from approaches targeting physical activity and stress management as well as dietary interventions, including general dietary patterns, individual food groups, supplements, and microbiota-directed strategies in the context of PD. Importantly, we also identify current knowledge gaps and provide an outlook for future strategies to implement multidimensional, disease-specific, and stratified lifestyle medicine in the prevention and treatment of PD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.